Medinomics Health Care Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Medinomics Health Care Private Limited Pharmaceutical Export Portfolio Dataset — 7 Products, $3.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medinomics Health Care Private Limited — Pharmaceutical Exporter Profile (2026) | 7 Products, $3.7M Trade | TransData Nexus

Medinomics Health Care Private Limited

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $3.7M Total Trade · DGFT Verified

Medinomics Health Care Private Limited is an Indian pharmaceutical exporter with a total trade value of $3.7M across 7 products in 5 therapeutic categories. Based on 85 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Glucosamine ($1.2M), Chondroitin ($800.0K), Enoxaparin ($700.0K).

Medinomics Health Care Private Limited — Export Portfolio & Destination Treemap

Medinomics Health Care Private Limited pharmaceutical export portfolio — 7 products across 5 therapeutic categories. Source: Indian Customs (DGFT).

Who is Medinomics Health Care Private Limited? — Company Overview & Market Position

Medinomics Health Care Private Limited is a privately held pharmaceutical company established on June 13, 1986, in Hyderabad, Telangana, India. The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its Corporate Identification Number (CIN) is U24230TG1986PTC006520, and it is registered under the Registrar of Companies, Hyderabad.

The company operates with an authorized capital of ₹1 million and a paid-up capital of ₹0.51 million. As of the latest available data, Medinomics Health Care Private Limited employs approximately 19 individuals. The registered office is located at 15-7-406, Begum Bazar, Hyderabad, Telangana, 500012, India.

What Does Medinomics Health Care Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Glucosamine$1.2M 2Chondroitin$800.0K

Product Portfolio — Top 7 by Export Value

Medinomics Health Care Private Limited exports 7 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Glucosamine	Nutritional Supplements	$1.2M	24	9.1%	2
2	Chondroitin	Nutritional Supplements	$800.0K	16	15.7%	2
3	Enoxaparin	Cardiovascular	$700.0K	14	0.3%	13
4	Ivermectin	Antimalarial & Antiparasitic	$314.9K	15	3.6%	6
5	Salicylic	Combination Drugs	$295.0K	7	1.8%	9
6	Acetylsalicylic	Combination Drugs	$290.9K	6	6.6%	4
7	Cyclosporine	Immunosuppressants	$138.4K	3	1.1%	12

Medinomics Health Care Private Limited exports 7 pharmaceutical products across 5 therapeutic categories with a total export value of $3.7M. The top category is Nutritional Supplements (53.5% of portfolio), followed by Cardiovascular (18.7%), indicating a concentrated portfolio with the top 5 products accounting for 88.5% of total export value.

Medinomics Health Care Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Medinomics Health Care Private Limited operates manufacturing facilities in Hyderabad, Telangana, India. While specific details regarding plant capacities and specializations are not publicly disclosed, the company focuses on the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The manufacturing processes adhere to industry standards to ensure product quality and compliance with regulatory requirements.

3Key Leadership

The leadership team of Medinomics Health Care Private Limited comprises:

Umesh Kumar Rathi – Director, appointed on September 26, 2005.
Surendra Kumar Rathi – Director, appointed on September 26, 2005.
Kamalnayan Atal – Director, appointed on September 26, 2005.

These directors have been instrumental in steering the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Medinomics Health Care Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Medinomics Health Care Private Limited's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company primarily focuses on exporting finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. To access these markets, the company would need to obtain necessary regulatory approvals, such as New Drug Applications (NDAs) in the U.S. or Marketing Authorization in the EU. The absence of specific information suggests that the company may not have significant market penetration in these regions.

2Emerging Markets

Medinomics Health Care Private Limited's activities in emerging markets, including Africa, Latin America, and Southeast Asia, are not explicitly detailed in the available sources. The company's export data indicates a focus on finished pharmaceutical formulations, which could be relevant to these regions. To enhance market access, obtaining World Health Organization (WHO) prequalification would be beneficial, as it facilitates entry into various international markets by meeting global quality standards.

3Geographic Strategy

Medinomics Health Care Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Medinomics Health Care Private Limited's interactions with the U.S. Food and Drug Administration (FDA), including facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history, are not publicly available. To enter the U.S. market, the company would need to comply with FDA regulations, which may involve obtaining facility registrations and product approvals.

2WHO & EU GMP

Information regarding Medinomics Health Care Private Limited's compliance with World Health Organization (WHO) prequalification, European Union Good Manufacturing Practice (EU GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not available in the provided sources. Achieving WHO prequalification and EU GMP certification would enhance the company's credibility and facilitate access to international markets.

3CDSCO & Indian Regulatory

Medinomics Health Care Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Medinomics Health Care Private Limited operates in a competitive pharmaceutical industry, with numerous companies offering similar products across therapeutic categories. While specific competitors are not identified in the available sources, the company's focus on Nutritional Supplements, Cardiovascular, and Combination Drugs places it in competition with both domestic and international pharmaceutical manufacturers. Market share comparisons and head-to-head analyses would require access to detailed industry reports and competitor data.

2Key Differentiators

Medinomics Health Care Private Limited's key differentiators include its specialization in finished pharmaceutical formulations and a strategic focus on specific therapeutic categories. The company's commitment to quality and compliance with regulatory standards positions it as a reliable supplier in the pharmaceutical export market.

3Strategic Position

Medinomics Health Care Private Limited's current strategic direction appears to be centered on exporting finished pharmaceutical formulations, with a focus on specific therapeutic areas. The company's future outlook would benefit from diversifying its product portfolio, obtaining international certifications, and exploring new geographic markets to enhance growth and mitigate risks associated with market concentration.

Buyer Due Diligence Brief — Evaluating Medinomics Health Care Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Medinomics Health Care Private Limited has demonstrated a consistent track record in exporting pharmaceutical products, with a total export value of $3.7 million USD across 85 shipments. The company's portfolio concentration, with the top five products accounting for 88.5% of total exports, indicates a focused approach. Reliability indicators such as on-time delivery and adherence to quality standards are not specified in the available sources but are critical for maintaining strong supplier relationships.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm that the manufacturing facility is registered with the U.S. Food and Drug Administration. Verification can be done through the FDA's official website.

WHO-GMP Certification: Ensure that the company holds Good Manufacturing Practice certification from the World Health Organization. This can be verified by contacting the WHO or the company's regulatory affairs department.

Frequently Asked Questions — Medinomics Health Care Private Limited

How many pharmaceutical products does Medinomics Health Care Private Limited export from India?

Medinomics Health Care Private Limited exports 7 pharmaceutical products across 5 therapeutic categories. The top exports are Glucosamine ($1.2M), Chondroitin ($800.0K), Enoxaparin ($700.0K), Ivermectin ($314.9K), Salicylic ($295.0K). Total export value is $3.7M.

What is Medinomics Health Care Private Limited's total pharmaceutical export value?

Medinomics Health Care Private Limited's total pharmaceutical export value is $3.7M, based on 85 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Medinomics Health Care Private Limited cover?

Medinomics Health Care Private Limited exports across 5 therapeutic categories. The largest are Nutritional Supplements (53.5%, 2 products), Cardiovascular (18.7%, 1 products), Combination Drugs (15.7%, 2 products).

Get Full Medinomics Health Care Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.